Scientists have discovered the two key processes that allow cancer cells to change the way they move in order to spread through the body, according to a new study.
The researchers who first isolated cancer stem cells in adult brain tumors in 2004 have now identified a molecular mechanism that is involved in the development of these cells from which malignant brain tumors may originate. This could offer a target for scientists seeking treatments that would kill malignant brain tumors at their source and prevent them from recurring.
Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, researchers have found. IDO, an enzyme that works like a firefighter to keep inflammation under control, can be commandeered to protect early malignant cells, say researchers studying an animal model of chronic inflammation and skin cancer.
Melanoma patients infused with a special type of tumor-fighting T cell are more likely to survive without relapse, suggests a new study by researchers in France.
New research reveals completely new properties of the skin’s stem cells – discoveries that contradict previous findings. The studies, which are published in Nature Genetics, show amongst other things, that hair follicle stem cells can divide actively and transport themselves through the skin tissue.
A novel anti-tumor vaccine for neuroblastoma and melanoma is showing significant impact on tumor growth in mice, according to new research published in Cancer Immunology, Immunotherapy. The vaccine uses the tumor's own protein to induce an immune system response, allowing for a personalized approach to treatment.
Cancer incidence is higher among liver transplant recipients in Finland compared to the general population, according to a new study.
Researchers have discovered how a gene, melanoma differentiation associated gene-9/syntenin (mda-9/syntenin), interacts with an important signaling protein to promote metastasis in human melanoma cells, a discovery that could one day lead to the development of the next generation of anti-metastatic drugs for melanoma and other cancers.
